Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Vishwanath Sathyanarayanan"'
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 1124-1133 (2020)
This review will compare and contrast the costs and access to novel drugs for treating chronic lymphocytic leukemia (CLL) and lymphoma in the United States and India during the last 5 years. Clinical outcomes for patients with hematologic malignancie
Externí odkaz:
https://doaj.org/article/cc393339519a45dc9eb5637a36459980
Autor:
Vishwanath Sathyanarayanan, Kadabur Nagendrappa Lokesh, Lakshmaiah KC, Govind Babu K, Lokanatha D, Suresh Babu MC, Clementina Rama Rao, Premalata Chennagiri
Publikováno v:
Annals of Saudi Medicine, Vol 34, Iss 6, Pp 551-554 (2014)
Non-Hodgkin lymphoma of the breast is an uncommon entity accounting for approximately 0.5% of malignant breast neoplasms and around 3% of extranodal lymphomas. Most cases of anaplastic large cell lymphoma (ALCL) of the breast have been associated wit
Externí odkaz:
https://doaj.org/article/4be47dff5e754c8fb9a7b5dad5badc84
Autor:
Anıl Kumar N., Vishwanath Sathyanarayanan, Visweswariah Lakshmi Devi, Namratha N. Rajkumar, Umesh Das, Sarjana Dutt, Lakshmaiah K Chinnagiriyappa
Publikováno v:
Turkish Journal of Hematology, Vol 31, Iss 1, Pp 56-60 (2014)
OBJECTIVE: Eosinophilia associated with FIP1L1-PDGFRA rearrangement represents a subset of chronic eosinophilic leukemia and affected patients are sensitive to imatinib treatment. This study was undertaken to learn the prevalence and associated clini
Externí odkaz:
https://doaj.org/article/4685337e6ef94779a98241aee4c42390
Primary Diffuse large B-Cell lymphoma of testis: A single centre experience and review of literature
Autor:
Kadabur Nagendrapp Lokesh, Vishwanath Sathyanarayanan, C Lakshmaiah Kuntegowdanahalli, T M Suresh, Lokanatha Dasappa, Govinda Babu K Kanakasetty
Publikováno v:
Urology Annals, Vol 6, Iss 3, Pp 231-234 (2014)
Background: Primary testicular lymphoma constitutes 1-2% of Non-Hodgkin′s lymphomas affecting elderly men >60 years of age. Most often it is a Diffuse large B cell lymphoma (DLBCL) and treatment involves multimodality approach involving surgery, ch
Externí odkaz:
https://doaj.org/article/da13fd2780a64e57b36b9064496d0059
Publikováno v:
Journal of the Scientific Society, Vol 41, Iss 3, Pp 183-185 (2014)
We present this unusual case of the clinical importance of a 50-year-old male patient who presented with foreign body sensation in the throat and halitosis of 20 days duration. On examination, there were no palpable lymph nodes and oral cavity reveal
Externí odkaz:
https://doaj.org/article/58fb1332719d41a6abf9f0aac2587e87
Autor:
Lakshmaiah KC, Vishwanath Sathyanarayanan, Lokesh KN, Premalatha CS, Clementina Rama Rao, Suresh TM, Govind Babu K, Lokanatha D, Linu Abraham Jacob, Umesh Das, Suresh Babu
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 1 (2014)
Background and Purpose: Primary parotid lymphoma (PPL) is an unusual entity and comprises 5% of salivary gland neoplasms and 5% of extra nodal lymphomas. There is limited data in Indian population. Hence we undertook this retrospective observationa
Externí odkaz:
https://doaj.org/article/7df99552127d49ceaebd38ebc81f690d
Autor:
Jason R. Westin, Raisa Pinto, Amir Issa, Vishwanath Sathyanarayanan, Sanam Loghavi, Luis Fayad, Fredrick B. Hagemeister
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:709-714
Background Rosai-Dorfman disease (RDD) is a rare disorder composed of a proliferation of histiocytes with varied clinical manifestations. Patients and Methods In this retrospective observational study, we obtained demographic, clinical, and outcome d
Publikováno v:
JCO Global Oncology
This review will compare and contrast the costs and access to novel drugs for treating chronic lymphocytic leukemia (CLL) and lymphoma in the United States and India during the last 5 years. Clinical outcomes for patients with hematologic malignancie
Publikováno v:
Phase I Oncology Drug Development ISBN: 9783030476816
Hematological Malignancies are at the forefront of rapid advances in molecular technology which has enabled the understanding of the biology and brought us to the cutting edge of diagnosis and therapy. Today, it is possible to routinely sequence the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::385583f25d3a75e74ff9441bfe8afa2e
https://doi.org/10.1007/978-3-030-47682-3_17
https://doi.org/10.1007/978-3-030-47682-3_17
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 16:e65-e70
Vanishing bile duct syndrome is an unusual entity characterized by progressive destruction of the intrahepatic bile ducts (ductopenia), which ultimately results in cholestasis. The pathogenesis is unclear and related to immunologic injury of bile duc